ObjectiveTo provide evidence-based consensus guidelines for the management of women
with cervical cytological abnormalities and cervical cancer precursors. ParticipantsA panel of …

OBJECTIVE: To evaluate the prevalence and histologic outcomes of patients with atypical
glandular cells of undetermined significance (AGUS), diagnosed by Pap test, and concurrent …

OBJECTIVE: This study was undertaken to examine routine cervical cancer screening
diagnoses and outcomes on an age-specific basis in a US population. STUDY DESIGN: We …

The current paper presents the first part of Chapter 6 of the second edition of the European
Guidelines for Quality Assurance in Cervical Cancer Screening. It provides guidance on how …

Abstract Context.—The Bethesda System for reporting cervical/vaginal cytologic diagnoses
introduced terminology for atypical squamous and glandular cells and categories for …

We intensively reviewed 137 smears initially classified as atypical glandular cells of
undetermined significance (AGUS) to refine cytological criteria for evaluating these cases …

BACKGROUND The current study was performed to compare the accuracy of the
ThinPrep™ Papanicoloau (Pap) test with that of the conventionally prepared Pap smear in …

OBJECTIVE: Although the ThinPrep Pap Test is replacing conventional Pap smears in many
clinical practices, experience with the identification of glandular lesions is limited. In this …

OBJECTIVES: To estimate the rates of and identify risk factors for disease in women with
atypical glandular cells of undetermined significance (AGUS). METHODS: From 1998–2001 …

OBJECTIVE: To estimate the risk of significant pathology from atypical glandular cell (AGC)
Pap tests classified by the 2001 Bethesda system and to assess potential differences in AGC …